Multicystic Peritoneal Mesothelioma: Outcomes and Patho-Biological Features in a Multi-Institutional Series Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

D. Baratti (1) , M. Vaira (2) , S. Kusamura (1) , S. d'Amico (2) , M.R. Balestra (1) , T. Cioppa (2) , E. Mingrone (1) , M. de Simone (2) , M. Deraco (1)

1 Department of Surgery
2 Department of General and Oncological Surgery

This retrospective multi-institutional study addresses the role of surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of multicystic peritoneal mesothelioma (MCPM). MCPM is an uncommon tumour with uncertain malignant potential and no current standard therapy. Additionally, poorly defined pathological and biological features of this disease were investigated.

Mots clés: multicystic peritoneal mesothelioma; cytoreductive surgery; peritonectomy; hyperthermic intraperitoneal chemotherapy; HIPEC

D. Baratti, M. Vaira, S. Kusamura, S. d'Amico, M.R. Balestra, et al.. Multicystic Peritoneal Mesothelioma: Outcomes and Patho-Biological Features in a Multi-Institutional Series Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). EJSO - European Journal of Surgical Oncology, 2010, 36 (11), pp.1047. ⟨10.1016/j.ejso.2010.08.130⟩. ⟨hal-00630331⟩